BridgeBio Pharma Inc Cash Flow Reinvestment Rate
Latest as of June 2024:
0.07x
BridgeBio Pharma Inc cash flow reinvestment rate. BridgeBio Pharma Inc (BBIO) has a Cash Flow Reinvestment Rate of 0.07x as of June 2024, reinvesting $5.49 Million (capex $2.45 Million plus investments $3.04 Million) from operating cash flow of $74.70 Million. Explore BBIO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.07x
(Capex + Investments) / Operating CF
Total Reinvested
$5.49 Million
Capex + Investments
Operating Cash Flow
$74.70 Million
USD
Capital Expenditures
$2.45 Million
USD
BridgeBio Pharma Inc Cash Flow Reinvestment Rate by Year (None–None)
BridgeBio Pharma Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for BridgeBio Pharma Inc. For the full cash flow conversion analysis, see BBIO operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow